Page 17 - Who
Haryana stops production at plant making cough syrups flagged by WHO
12 violations found at Maiden Pharmaceuticals' Sonipat facility, says state health minister
 "Haryana stops production at plant making cough syrups flagged by WHO")
Who is responsible for the quality of Indian pharma exports?
WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?
 "Who is responsible for the quality of Indian pharma exports?")
Top headlines: Growth forecast, Maiden Pharma cough syrup issue, and more
From World Bank slashing India's economic growth to Maiden Pharma's cough syrup issue, here are the top headlines on Friday morning
 "Top headlines: Growth forecast, Maiden Pharma cough syrup issue, and more")
Who is responsible for the quality of Indian pharma exports?
WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?
Maiden Pharma's cough syrups, under WHO scanner, not sold in India: Sources
Meanwhile, the Indian regulator is awaiting evidence of links between the cough syrups and the deaths in Gambia
WHO issues alert for 4 India-made cough syrups; check symptoms here
WHO has asked not to use these four products until analysed by the relevant national regulatory authorities
 "WHO issues alert for 4 India-made cough syrups; check symptoms here")
Cough syrups by Indian firm potentially tied to 66 deaths in Gambia: WHO
WHO issued a medical product alert for the four syrups and said it was conducting further investigation with New Delhi-based Maiden Pharmaceuticals and regulatory authorities in India
End of the pandemic in sight, but is it time to let down the guard?
While the world is moving away from the most basic Covid-19 protocols, some experts say it is too early to declare that the pandemic is over
 "End of the pandemic in sight, but is it time to let down the guard?")
WHO launches new initiative to stop invasive malaria vector in Africa
A new World Health Organization (WHO) initiative has been launched that aims to stop the further spread of this invasive mosquito species in the region.The WHO had identified the spread of Anopheles stephensi as a significant threat to malaria control and elimination in 2019 - particularly in Africa, where the disease hits hardest.Originally native to parts of South Asia and the Arabian Peninsula, An. stephensi has been expanding its range over the last decade, with detections reported in Djibouti (2012), Ethiopia and Sudan (2016), Somalia (2019) and Nigeria (2020).Unlike the other main mosquito vectors of malaria in Africa, it thrives in urban settings, the WHO said."With more than 40 per cent of the population in Africa living in urban environments, the WHO said the invasion and spread of An. stephensi could pose a significant threat to the control and elimination of malaria. But large-scale surveillance of the vector is still in its infancy, and more research and data are urgently .
 "WHO launches new initiative to stop invasive malaria vector in Africa")
Arogya World wins the prestigious UN award for initiative against NCD
/ -- Arogya World is thrilled to be selected as a recipient of the 2022 UN Interagency Task Force and the WHO Special Programme on Primary Health Care Award. The award recognized Arogya World for its work in scaling up community-based delivery models to strengthen prevention and control of diabetes at the population level, across 19 states in India. Expressing her views, Dr Nalini Saligram, Founder & CEO, Arogya World, said, "This is a proud moment for us, as Arogya World is the only non-profit working in India to receive this prestigious award. This is global recognition for the work that my team has been doing for more than a decade, working tirelessly on the prevention of NCDs at the population level in India. We thank Dr Venkat Narayan from Emory University for nominating us, and thank all our partners and supporters for helping us improve the health of millions of Indians throughout our vast country. This award spurs us on to do more, with a greater sense of responsibility, ..
 "Arogya World wins the prestigious UN award for initiative against NCD")
WHO researcher Rajiv Bahl is new ICMR head and secy, health research
Bahl joined WHO in 2003 where he coordinates research and guidelines development in areas of maternal, newborn, child and adolescent health; was earlier with AIIMS
 "WHO researcher Rajiv Bahl is new ICMR head and secy, health research")
Is the end of the Covid-19 pandemic in sight for India?
WHO chief has finally said that the world has never been better placed to end the Covid-19. But, are we really seeing the end of the pandemic? Should we lower our guard and shelve the masks?
 "Is the end of the Covid-19 pandemic in sight for India?")
WHO warns of '2nd disaster' in Pakistan amid fears of water-born diseases
WHO expressed grave fears over what it termed to be a "second disaster" in the flood-hit Pakistan, where massive areas are left with standing water triggering water-borne diseases
World Patient Safety Day: WHO stresses on ending unsafe medication practice
On World Patient Safety Day, WHO on Saturday highlighted the need to prevent avoidable harm in healthcare systems with a focus on ending unsafe medication practices and errors. In addition to causing significant disability and death, unsafe medication practices and errors cost an estimated USD 42 million around the world annually. In low- and middle-income countries including in the WHO South-East Asia Region patient harm due to unsafe care contributes to an estimated 134 million adverse events annually resulting in around 2.6 million deaths, WHO Regional Director for South-East Asia Dr Poonam Khetrapal Singh said. Unsafe medication practices and errors can occur at different stages. It can result from weak medication systems or human factors such as fatigue, poor environmental conditions or staff shortages, she said in a statement. Since 2015, the WHO South-East Asia Region has made targeted efforts to reduce unsafe medication practices and errors with a focus on addressing ...
 "World Patient Safety Day: WHO stresses on ending unsafe medication practice")
WHO strongly advises against use of 2 Covid-19 antibody therapies: BMJ
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal. In the same guideline update, WHO makes a conditional recommendation for the use of the antiviral drug remdesivir in patients with severe COVID-19, and a conditional recommendation against its use in patients with critical disease. The WHO Guideline Development Group of international experts noted that antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with COVID-19. These drugs work by binding to the SARS-CoV-2 spike protein -- which helps the virus to enter the cells -- neutralising its ability to infect. The "strong" recommendation replaces previous conditional recommendations for their use and is based on emerging evidence from laboratory studies that these drugs are not likely to work against currently ...
 "WHO strongly advises against use of 2 Covid-19 antibody therapies: BMJ")
WHO saying end of pandemic within reach falls flat in Covid zero China
Chinese are reacting with pessimism and humor to the World Health Organization chief saying the end of the pandemic is within reach, with millions of people still locked down
 "WHO saying end of pandemic within reach falls flat in Covid zero China")
Covid-19 deaths lowest since March 2020, end of pandemic in sight: WHO
WHO chief said that the number of weekly reported deaths from Covid-19 last week plunged to its lowest since March 2020 and added that the end of the pandemic is now in sight.
 "Covid-19 deaths lowest since March 2020, end of pandemic in sight: WHO")
Top Headlines: Petro products export share rises; RBI rate hike, and more
With the price index surprising on the upside in August, many analysts have pencilled in a higher inflation print in September as well and accordingly expect the RBI to frontload policy rate hikes
 "Top Headlines: Petro products export share rises; RBI rate hike, and more")
'Covid end in sight, deaths at lowest since March 2020,' says WHO
The head of the World Health Organization said Wednesday that the number of coronavirus deaths worldwide last week was the lowest reported in the pandemic since March 2020, marking what could be a turning point in the years-long global outbreak. At a press briefing in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus said the world has never been in a better position to stop COVID-19. We are not there yet, but the end is in sight, he said, comparing the effort to that made by a marathon runner nearing the finish line. Now is the worst time to stop running, he said. Now is the time to run harder and make sure we cross the line and reap all the rewards of our hard work. In its weekly report on the pandemic, the U.N. health agency said deaths fell by 22% in the past week, at just over 11,000 reported worldwide. There were 3.1 million new cases, a drop of 28%, continuing a weeks-long decline in the disease in every part of the world. Still, the WHO warned that relaxed COVID testi
17 mn in Europe experienced long Covid; WHO urges nation to find solution
At least 17 million people in the World Health Organisation (WHO) European Region experienced the post-Covid-19 condition, or long Covid, in the first two years of the pandemic
